PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT05172596 · TERMINATED
Trial details
- NCT number
- NCT05172596
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-03
- Primary completion
- 2025-05-21
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.